Atomera positions itself as a materials and process IP provider rather than a traditional chipmaker, with a business model centered on developing, commercializing, and licensing MST technology to semiconductor companies. Recent technical breakthroughs include manufacturability of MST on Gate-All-Around structures and a top 20 semiconductor company running GaN wafers with MST.
Cyborg Score Rationale
Full-year revenue slipped to $65K as Atomera logged a $20.2M net loss and $16.1M adjusted EBITDA loss. Revenue has declined 53.46% over three years with significant operational inefficiencies, negative ROA and ROE. However, technical breakthroughs in MST and GaN-on-Silicon advancement with top-20 semiconductor partners offer speculative upside.
Top Insights
Achieved manufacturability breakthrough on Gate-All-Around transistors; top-20 semiconductor customer now running GaN wafers with MST; GaN-on-Silicon advancing to PowerAmerica funding proposal phase.
Cash position of $19.2M as of Dec 31, 2025, down 28% from prior year, providing ~2 years of runway at current burn rate.
Atomera has built a substantial IP portfolio around MST with hundreds of issued and pending patents.
Low debt-to-equity ratio of 0.04 shows robust capital structure despite negative profitability metrics.
GaN Power Semiconductors — Direct competitors in GaN power semiconductor applications
Recent Developments
(February 2026) Announced Q4 2025 results showing $20.2M net loss, $65K revenue, but technical breakthroughs in MST for Gate-All-Around and first commercial GaN customer; stock surged 64% on announcement
(February 2026) GaN-on-Silicon concept paper advanced to PowerAmerica proposal phase for potential government funding
(January 2026) Multiple GaN funding milestone announcements driving positive sentiment
Open the full interactive Atomera Incorporated report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.